Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of oral isotretinoin on skin photosensitivity in moderate to severe acne
ChiCTR2300071040Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of isotretinoin in acne vulgaris, sponsored by West China Hospital of Sichuan University. Primary endpoints: Minimum erythema dose (MED), Minimal persistent pigment darkening dose (MPPD) and 1 more. Started May 2023; status: recruiting.
02
Drugs
isotretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on ChiCTR2300071040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071040.